A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies

M Longoni, A Bertini, N Schifano, E Zaffuto… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Erectile dysfunction (ED) affects between 12.9% and 28.1% of men worldwide,
presenting a strong aged-correlated prevalence. Several pharmacological treatments are …
被引用次数：3 相关文章

A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies

M Longoni, A Bertini, N Schifano… - Expert opinion on …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Erectile dysfunction (ED) affects between 12.9% and 28.1% of men worldwide,
presenting a strong aged-correlated prevalence. Several pharmacological treatments are …

A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies

M Longoni, A Bertini, N Schifano, E Zaffuto… - EXPERT OPINION ON …, 2023 - iris.unisr.it
IntroductionErectile dysfunction (ED) affects between 12.9% and 28.1% of men worldwide,
presenting a strong aged-correlated prevalence. Several pharmacological treatments are …

A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies

M Longoni, A Bertini, N Schifano… - EXPERT OPINION …, 2023 - irinsubria.uninsubria.it
IntroductionErectile dysfunction (ED) affects between 12.9% and 28.1% of men worldwide,
presenting a strong aged-correlated prevalence. Several pharmacological treatments are …